1111111111

Grant Opportunities

CMT4B3 Research Foundation Grant

Hunter’s CMT4B3 Research Foundation will grant awards to principal investigators, physician residents, hospitals, universities and clinicians who are interested in studying CMT4B3. Our grants are intended to help researchers explore novel ideas and answer questions related to the clinical aspects, therapies and/or genetic causes of CMT4B3.

Research proposals will be carefully vetted by the Scientific Advisory Board. The Board evaluates each proposal based on the excellence of the investigator, the work plan and the environment, as well as the project’s ability to be translated into treatments for people with CMT4B3.  For more information on this opportunity, please click here.  Questions? Please contact Alessandra Bolino, bolino.alessandra@hsr.it  and  Robin Schultz, info@cmt4b3research.org.

U.S. National Institutes of Health (NIH) Opportunities

NOT-AT-21-017: NOITP a Funding Opportunity Announcement for HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trials Required)

  • Purpose: To support multisite effectiveness clinical trials of multicomponent nonopioid pharmacologic and nonpharmacologic approaches for acute and/or chronic SCD pain management.
  • Overall Goal: To inform clinicians about the effectiveness of coordinated, multidisciplinary management strategies that reduce acute and/or chronic SCD pain and continue to provide access to opioid pain management, when needed.
  • Clinical trials will be conducted as part of the HEAL Initiative Pain Management Effectiveness Research Network, which has dedicated pain and clinical trial design expertise and was established through the infrastructure of the National Center for Advancing Translation Sciences Trial Innovation Network (www.trialinnovationnetwork.org).

NOT-AT-21-018: NOITP a Funding Opportunity Announcement for HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional)

  • Purpose: To support multisite pragmatic or implementation trials to inform the uptake of non-opioid pharmacologic and nonpharmacologic approaches for acute and chronic SCD pain management in health care systems that serve the SCD population.
  • Overall Goal: To support the “real world” assessment of pain management interventions and health care strategies to enhance adherence to pain management guidelines in health care systems and improve SCD pain management, allowing access to opioid pain management, when needed.
  • Clinical trials will be conducted within partnering health care systems identified by the applicants. Trials will work with the Resource Coordinating Center for the HEAL Initiative Pragmatic and Implementation Studies for the Management of Pain to Reduce Opioid Prescribing (PRISM) program, which has dedicated pain, implementation science, and pragmatic clinical trial design expertise (heal.nih.gov/research/clinical-research/prism).

Supported trials should address the impact of interventions on psychological and functional outcomes that support improved overall well-being and quality of life. In addition, studies that address stigma, structural health care system, and social factors that may hinder quality comprehensive pain care for patients with SCD are also of interest. 

For full details on the anticipated research objectives of these funding opportunities, please refer to NOT-AT-21-017 and NOT-AT-21-018.

These FOAs are expected to be published in early fall 2021, with an expected application due date in late fall 2021. Both FOAs will utilize the UG3/UH3 activity code.  

AFM & GBS Grants – The NIAID, NINDS, and NICHD have jointly issued a Notice of Special Interest encouraging new applications and request for supplements to existing grants (competitive revisions or administrative supplements) to support basic, translational, and/or clinical research on the causes, diagnosis, prevention or treatment of Acute Flaccid Myelitis (AFM), Guillain-Barre Syndrome (GBS), and other acute neurological conditions. For more information, click here

Early Career Reviewer (ECR) Program – The program aims to help early career scientists become more competitive as grant applicants through first-hand experience with peer review and to enrich and diversify CSR’s pool of trained reviewers. Click here for more information.

U.S. Department of Defense Peer Reviewed Medical Research Program

The Department of Defense maintains a Peer Reviewed Medical Research Program to support research across the full range of science and medicine, with an underlying goal of enhancing the health, care, and well-being of military service members, veterans, retirees, and their family members. Projects related to peripheral neuropathy are eligible to apply for funding through this program thanks to the partnership between the Foundation for Peripheral Neuropathy and key congressional partners. For more information, click here (projects including all forms of peripheral neuropathy are welcome to apply). 

Have a grant opportunity you would like to list on our website? Please contact the PNS Executive Office at info@PNSociety.com.

Why Join the PNS?